RHA Collection filler guides, dynamic movement claims, comparisons, and patient fit.
RHA duration is PMA- and area-specific. Manufacturer up-to-15-months is a 64-week NLF follow-up, not a median. Dynamic Volume midface is S048 18 Sep 2025, not the 13 Jan…
FDA approved RHA Redensity Eye on 12 May 2026 for infraorbital hollows. It is a 15 mg/g gel, the fourth on-label HA, not the first under-eye filler.
A regulatory and clinical profile analyzing Teoxane's RHA Collection, its single FDA PMA P170002 architecture, Preserved Network Technology, and post-market safety data.
20 original PMA approvals since 1981, 1,036 total PMA records, and a recent wave of new entrants: what the FDA premarket-approval database reveals about who makes the…